SUPPLEMENTAL OCTREOTIDE CONTINGENT STOCK RIGHTS AGREEMENTSupplemental Octreotide Contingent Stock Rights Agreement • March 23rd, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
THIS SUPPLEMENTAL OCTREOTIDE CONTINGENT STOCK RIGHTS AGREEMENT (this “Supplemental Agreement”), dated as of March 23, 2009, is entered into by and among Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Endo Pharmaceuticals Holdings Inc., a Delaware corporation (“Endo”) and American Stock Transfer & Trust Company, as rights agent (the “Rights Agent”).
